CymaBay Therapeutics, Inc. - stock earnings
CBAY Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -41.9 million USD | 57000 USD |
| 2023Q3 | -33.9 million USD | ? USD |
| 2023Q2 | -808000 USD | 31.0 million USD |
| 2023Q1 | -35.1 million USD | ? USD |
| 2022Q4 | -36.4 million USD | ? USD |
| 2022Q3 | -27.6 million USD | ? USD |
| 2022Q2 | -30.4 million USD | ? USD |
| 2022Q1 | -31.0 million USD | ? USD |
| 2021Q4 | -26.5 million USD | ? USD |
| 2021Q3 | -22.7 million USD | ? USD |
| 2021Q2 | -23.2 million USD | ? USD |
| 2021Q1 | -17.6 million USD | ? USD |
| 2020Q4 | -15.8 million USD | ? USD |
| 2020Q3 | -11.4 million USD | ? USD |
| 2020Q2 | -10.7 million USD | ? USD |
| 2020Q1 | -13.1 million USD | ? USD |
| 2019Q4 | -29.4 million USD | ? USD |
| 2019Q3 | -26.3 million USD | ? USD |
| 2019Q2 | -24.0 million USD | ? USD |
| 2019Q1 | -23.1 million USD | ? USD |
| 2018Q4 | -19.4 million USD | ? USD |
| 2018Q3 | -18.6 million USD | ? USD |
| 2018Q2 | -17.5 million USD | ? USD |
| 2018Q1 | -17.0 million USD | 5.2 million USD |
| 2017Q4 | -5.0 million USD | 5.2 million USD |
| 2017Q3 | -8.2 million USD | ? USD |
| 2017Q2 | -8.9 million USD | 4.8 million USD |
| 2017Q1 | -5.4 million USD | 4.8 million USD |
| 2016Q4 | -7.0 million USD | ? USD |
| 2016Q3 | -5.9 million USD | ? USD |
| 2016Q2 | -7.0 million USD | ? USD |
| 2016Q1 | -6.8 million USD | ? USD |
| 2015Q4 | -6.0 million USD | ? USD |
| 2015Q3 | -5.9 million USD | ? USD |
| 2015Q2 | -1.4 million USD | ? USD |
| 2015Q1 | -2.3 million USD | ? USD |
| 2014Q4 | -12.7 million USD | ? USD |
| 2014Q3 | -6.0 million USD | ? USD |
| 2014Q2 | -3.2 million USD | ? USD |
| 2014Q1 | -10.1 million USD | ? USD |
| 2013Q4 | -3.9 million USD | ? USD |
| 2013Q3 | -1.3 million USD | ? USD |
| 2013Q2 | -2.2 million USD | ? USD |
| 2013Q1 | -2.6 million USD | ? USD |
| 2012Q4 | ? USD | 13000 USD |
| 2012Q3 | ? USD | 2.9 million USD |
| 2012Q2 | ? USD | 124000 USD |
CBAY Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -105.4 million USD | 31.1 million USD |
| 2022 | -118.9 million USD | 31.0 million USD |
| 2021 | -92.6 million USD | ? USD |
| 2020 | -48.7 million USD | ? USD |
| 2019 | -102.2 million USD | ? USD |
| 2018 | -72.5 million USD | ? USD |
| 2017 | -27.6 million USD | 10.0 million USD |
| 2016 | -26.7 million USD | ? USD |
| 2015 | -15.5 million USD | ? USD |
| 2014 | -31.9 million USD | ? USD |
| 2013 | -10.1 million USD | ? USD |
| 2012 | -11.3 million USD | 3.1 million USD |
CBAY
Price: $32.48
52 week price:
Earnings Per Share: -0.93 USD
P/E Ratio: -34.58
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 528000
Ebitda: -8.0 millionMarket Capitalization: 3.7 billion